---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-021213"
form_type: "8-K"
ticker: "FRMM"
cik: "0001690080"
company_name: "FORUM MARKETS Inc"
filed_at: "2024-03-11T23:59:59+00:00"
generated_at: "2026-06-04T23:52:52.163814+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Sir Marc Feldmann resigns; 180 Life Sciences appoints two independent directors

## Summary
- Sir Marc Feldmann resigned as director effective March 7, 2024; not due to any disagreement.
- Board appointed Omar Jimenez and Ryan L. Smith as Class II directors, effective March 7, 2024.
- Board size set to five; committees reorganized; Jimenez chairs Audit, Smith chairs Compensation & Nominating.
- Each new director receives $40k/yr retainer plus $10k chair fees; option for half cash/half stock or all cash with half accrued until $1M raise.
- With appointments, board now has majority independent members; all three committees fully independent.

## SEC filing metadata
- accession: 0001213900-24-021213
- form_type: 8-K
- ticker: FRMM
- cik: 0001690080
- company_name: FORUM MARKETS Inc
- filed_at: 2024-03-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1690080/000121390024021213/0001213900-24-021213-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1690080/000121390024021213/ea0201449-8k_180life.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-021213
- JSON: https://secwatch.observer/filing/0001213900-24-021213.json
- Plain text: https://secwatch.observer/filing/0001213900-24-021213.txt

## Key facts
- Executive change
  Sir Marc Feldmann resigned as Director at FORUM MARKETS Inc.
  - Action: resigned
  - Role: Director
  source text: On March 7, 2023, Sir Marc Feldmann, Ph.D. provided notice to the Board of Directors of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) of his resignation as a member of the Board of Directors, effective on the same date (March 7, 2024).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390024021213/0001213900-24-021213-index.htm
- Executive change
  Omar Jimenez was appointed as Director at FORUM MARKETS Inc.
  - Action: appointed
  - Role: Director
  source text: the Board of Directors of the Company appointed Omar Jimenez and Ryan L. Smith (collectively, the “ Appointees ” and the “ Appointments ”) as members of the Board of Directors (“ Board ”), which Appointments were effective as of the same date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390024021213/0001213900-24-021213-index.htm
- Executive change
  Ryan L. Smith was appointed as Director at FORUM MARKETS Inc.
  - Action: appointed
  - Role: Director
  source text: the Board of Directors of the Company appointed Omar Jimenez and Ryan L. Smith (collectively, the “ Appointees ” and the “ Appointments ”) as members of the Board of Directors (“ Board ”), which Appointments were effective as of the same date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390024021213/0001213900-24-021213-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.